ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

NIPT Premaitha

9.10
0.00 (0.00%)
Last Updated: 00:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Premaitha LSE:NIPT London Ordinary Share GB00BN31ZD89 ORD 0.1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 9.10 9.00 9.20 - 0.00 00:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Premaitha Share Discussion Threads

Showing 4301 to 4320 of 6500 messages
Chat Pages: Latest  176  175  174  173  172  171  170  169  168  167  166  165  Older
DateSubjectAuthorDiscuss
06/2/2017
16:17
Interesting.....
fse
06/2/2017
16:11
Roche bought Ariosa for est $323M Illumina bought Verinata for $350M +
Premaitha is valued at @$20M

If someone can oblige what are the main reasons Premaitha test is superior to Natera Panorama.... thanks

fse
06/2/2017
15:52
This is a distribution Lab they don't make the test. BATM have rights to Natura Panorama test and they want to use Zer Labs to analyise this.
Wondering why BATM would not look at Premaitha solution.....

fse
06/2/2017
14:13
No CE mark as far as I know, so inferior product to Iona, takes 7-14 days for results and looks expensive, apart from that ??
hjb1
06/2/2017
13:57
Company I have shares in just made this acquisition. Looks similar to Premaitha.
Not really following NIPT but have a very small holding in them... inherited from earlier days !
Any views on Zer Labs or the tech they are using.....


6 February 2017

BATM Advanced Communications Limited

("BATM" or "the Group")

BATM Acquires Zer Laboratories Ltd

BATM Advanced Communications Limited (LSE: BVC), a leading provider of real-time technologies for networking solutions and medical laboratory systems, is pleased to announce that it has entered into an agreement (the "Agreement") to purchase the entire issued share capital of Zer Laboratories Ltd. ("Zer Laboratories") for a consideration of NIS 2.75 million (approx. GBP580,000) payable in cash (the "Acquisition").

Overview of Zer Laboratories

Zer Laboratories, headquartered in Tel Aviv, Israel and established in 1976, is the largest private diagnostic laboratory in Israel for clinical tests, mainly providing prenatal screening tests for Down's Syndrome, genetic tests and additional tests performed during IVF and fertility treatments.

Zer Laboratories unaudited revenues for full year 2015 amounted to $2.4 million and profit before tax was $27,000. The Acquisition is expected to be earnings accretive in the financial year ending 31 December 2017.

Rationale for the Acquisition

The Acquisition is in line with the Group's stated strategy of becoming a prominent participant in the diagnostics markets in which it operates. The primary reasons for the Acquisition are:

-- Synergies with BATM's existing offering of non-invasive prenatal tests (NIPT) using Panorama, the NIPT of Natera, which determines the chance that a pregnancy has certain chromosomal abnormalities; Natera is a NASDAQ-listed company offering proprietary bioinformatic solutions that enable laboratories worldwide to expand their test offerings; Natera granted distribution rights to BATM in Israel and Romania.

fse
05/2/2017
16:55
Try AAA's in your torch!
elrico
05/2/2017
14:39
I would be worried No contracts burning money. Just can not see any light at end of tunnel. Got to be a cash call very soon as well. Going on for far too long.
thinkbig?
05/2/2017
01:07
Has replaced"watching paint dry"
gooosed
03/2/2017
12:24
Ridiculous
timojelly
24/1/2017
08:53
Really getting bored of this..
timojelly
19/1/2017
22:19
Thanks hjb.
elrico
19/1/2017
15:43
elrico; to avoid any doubt it is the chap who works for Hardman who deals with the Premaitha work/report, sorry for any confusion!
hjb1
19/1/2017
13:27
HJB - You stated it was from someone "working with Hardman" NOT Hardman. October, senior moment on my part, it was a ref to July CC of course. I don't mean to be disingenuous to you, just cautious.

I don't post often and more than BSS would like I would wager, but can we at least agree to stick to NIPT and not get involved with the loonies that invested in the CTAG fraud and now badger bait TW because he called the fraud for what it IS! There must be 5-6 CTAG gimps posting here and all seemingly attempting to discolour NIPT by TW association.

elrico
19/1/2017
10:59
No,I don't.

You cannot research future court rulings on exporting to avoid a patent ruling you lost. It is as Hardman said 'it could be possible' no more than that.
or put another way, then yes, he did research and realised it might/may/could be possible. What I say is equally possible.....and this is PAID FOR RESEARCH/REPORT which must be taken into account. It's the best foot forward requiring a basis of fact/possibilities. imv it may be misleading to read too much into this "possiblity"and I just hope we win if it goes to court because I have little confidence with this particular Hardman hope if we lost. aimho

n'est pas?

twix386
19/1/2017
10:55
Twix, I would think the guy would have researched heavily the possibility to circumvent before he published it,don't you?.let's face it all they are doing is taking a blood sample m'lud, and nobody has a patent for that! lol
hjb1
19/1/2017
10:54
I would settle for an out of court too.

There was a time I wanted to go to court and win. That was when things looked and felt and was stated as much better and there was less concern and never ending commercial damage.

Illumina, if they settle are bound to wait to the last minute to cause us maximum damage.
Facilitated as we delayed for a year to partner Ariosa which is only relevant to invalidity argument - not the 'we do not infringe anyway'. I always thought the delay if we had a strong case that we did not infringe, was a mistake and I remain (at 8p and terrible contract delivery) of the same view except that subsequently it's since been stated we now do not expect a binary outcome. ahhhhh

twix386
19/1/2017
10:47
yes, ultimately it will only be the opinion of the courts, if it ever gets that far? Whilst it is his opinion he still would want to keep a bit of credibility even if they have been paid.
I would settle for an "out of court" any day..

hjb1
19/1/2017
10:42
Re Hardman report.

My conclusion is we have a good chance to win and I am hopefull on the data that supports a win and must remain confidential, but I am less convinced by the export of our results to Taiwan for analysis argument though I am sure IONA can be used in these other markets where there is no Illumina patent, of course.

The area I take issue with the paid for view is because even Hardman say at best they believe "it could" be possible. I foresee Illumina seeking a ruling on export of the core data out of Europe specifically to circumvent patents? Illumina would of course look at this development and seek any and all opportunities to confront this. Yourgene is currently doing this method themselves, as Hardman make sure to tell us, but of course not a single core test result Yourgene collects comes from Europe where there is a patent in force, so that comparrision is almost irrelevant imv. It is felt no more than a reasonable possibility for us if we lose the patent and Hardman are imv talking it up. If we lose the patent I feel it is also at least a reasonable possibility that Illumina will have plugged this possibility or at the very least would then seek to stop us exporting based on their victory not allowing a clear breach of the spirit of the ruling. It's a good story to tell and has possibilties, but it's one sided with caveats imho.

It looks likely IF Illumina settle, it will only be late in the day. So if we run that late we would rather go to court? I bet we will settle if offered acceptable terms at any time and assuming we have a strong enough case as told that would be disapointing - not as disappointing as losing though. lol

twix386
19/1/2017
10:08
hi - I hope the Doc from Hardman is on the money but it is just an opinion and what's more, one that's effectively been paid for. He/she will inevitably have to defer to the court decision in due course or a pre-court settlement (not my preferred option tbh) so as topically interesting as it is - it remains just that.
gooosed
19/1/2017
09:53
gooosed, but I have an authenticated source!! Not comfortable in divulging though, having said that he couldn't have thought what he sent was a problem to put into the public domain and did not ask it to stay confidential so....
hjb1
Chat Pages: Latest  176  175  174  173  172  171  170  169  168  167  166  165  Older

Your Recent History

Delayed Upgrade Clock